SQUAMOUS NON-SMALL-CELL LUNG CANCER
Clinical trials for SQUAMOUS NON-SMALL-CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS NON-SMALL-CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for SQUAMOUS NON-SMALL-CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug targets specific protein in advanced tumors
Disease control Recruiting nowThis early-stage trial is testing a new drug called ALE.P03 in adults with advanced or spreading cancers that have a specific protein marker (CLDN1+). The study aims to find a safe and effective dose and see if the drug can shrink tumors. It will enroll 180 patients with cancers …
Matched conditions: SQUAMOUS NON-SMALL-CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Alentis Therapeutics AG • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New weapon tested in fight against advanced cancers
Disease control Recruiting nowThis early-stage trial is testing a new drug called AZD8205, both by itself and combined with other cancer drugs, for people with advanced solid tumors that have spread or returned. The main goals are to find safe doses and see if the treatments can shrink tumors. It is enrolling…
Matched conditions: SQUAMOUS NON-SMALL-CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Personalized vaccine trial aims to boost immune attack on lung cancer
Disease control Recruiting nowThis study is testing if adding a new personalized cancer vaccine called V940 to standard immunotherapy and chemotherapy helps people with advanced squamous non-small cell lung cancer live longer and keeps their cancer from growing. The trial will compare results for 180 particip…
Matched conditions: SQUAMOUS NON-SMALL-CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New pill targets advanced cancers in first human trial
Disease control Recruiting nowThis is an early-stage study to test a new oral medication called VLS-1488 in adults with advanced solid tumors. The main goals are to find a safe dose and see if the drug shows any early signs of helping to control the cancer. The study is for people with specific advanced cance…
Matched conditions: SQUAMOUS NON-SMALL-CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Volastra Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New 'Smart Bomb' drug targets tough cancers in major trial
Disease control Recruiting nowThis study is testing a new experimental drug called ALE.P02 for adults with advanced squamous cell cancers that have spread or can't be removed by surgery. The drug is designed to target cancer cells that have a specific marker called Claudin-1. Researchers will first find the s…
Matched conditions: SQUAMOUS NON-SMALL-CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Alentis Therapeutics AG • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC